Aquamarine Synthetics And Chemicals Profile
Key Indicators
- Authorised Capital ₹ 1.56 Cr
- Paid Up Capital ₹ 1.56 Cr
- Company Age 17 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth %
- Profit Growth 48.96%
- Ebitda 44.95%
- Net Worth -13.74%
- Total Assets -36.67%
About Aquamarine Synthetics And Chemicals
Aquamarine Synthetics And Chemicals Private Limited (ASACPL) is a Private Limited Indian Non-Government Company incorporated in India on 14 September 2007 and has a history of 17 years and four months. Its registered office is in Delhi, India.
The Company is engaged in the Manufacturing Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.56 Cr and a paid-up capital of Rs 1.56 Cr, as per Ministry of Corporate Affairs (MCA) records.
Alok Dhir, Madhav Dhir, and Srishti Dhir serve as directors at the Company.
Company Details
-
Location
Delhi, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24233DL2007PTC168193
-
Company No.
168193
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
14 Sep 2007
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Aquamarine Synthetics And Chemicals?
Board Members (3)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Madhav Dhir | Director | 01-Sep-2018 | Current |
Alok Dhir | Director | 01-Nov-2022 | Current |
Srishti Dhir | Director | 01-Sep-2020 | Current |
Financial Performance of Aquamarine Synthetics And Chemicals.
Aquamarine Synthetics And Chemicals Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 48.96% increase in profit. The company's net worth observed a substantial decline by a decrease of 13.74%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
|
||||||
Revenue from Operations |
|
||||||
Total Assets |
|
||||||
Profit or Loss |
|
||||||
Net Worth |
|
||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Aquamarine Synthetics And Chemicals?
In 2022, Aquamarine Synthetics And Chemicals had a promoter holding of 74.52% and a public holding of 25.48%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Aquamarine Synthetics And Chemicals?
Unlock and access historical data on people associated with Aquamarine Synthetics And Chemicals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Aquamarine Synthetics And Chemicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aquamarine Synthetics And Chemicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.